Patents by Inventor Joyce S. Plested

Joyce S. Plested has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETECTING ANTI-SARS-COV-2 SPIKE (S) IMMUNOGLOBULINS
    Publication number: 20250085282
    Abstract: Disclosed are methods for detecting if a biological sample (e.g., serum, blood, plasma) contains antibodies against SARS-CoV-2 S glycoproteins comprising: (i) providing a surface coated with a SARS-CoV-2 S glycoprotein; (ii) exposing the surface to the biological sample; (iii) exposing the surface to a secondary antibody; and (iv) detecting the secondary antibody that is bound to the surface; wherein the biological sample contains antibodies that bind to the SARS-CoV-2 S glycoprotein if secondary antibody is detected.
    Type: Application
    Filed: September 11, 2024
    Publication date: March 13, 2025
    Inventors: Joyce S. PLESTED, Raj KALKERI
  • Vaccine
    Publication number: 20100016560
    Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 21, 2010
    Applicant: Isis Innovation Ltd.
    Inventors: Joyce S. Plested, Michael P. Jennings, Margaret Ann J. Gidney, Andrew D. Cox, James C. Richards, E. Richard Moxon
  • Vaccine
    Publication number: 20100015175
    Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 21, 2010
    Applicant: Isis Innovation Ltd.
    Inventors: Joyce S. Plested, Michael P. Jennings, Margaret Anne Gidney, Andrew D. Cox, James C. Richards, E. Richard Moxon
  • Vaccine
    Publication number: 20100010211
    Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.
    Type: Application
    Filed: July 24, 2009
    Publication date: January 14, 2010
    Applicant: Isis Innovation Ltd.
    Inventors: Joyce S. Plested, Michael P. Jennings, Margaret Anne Gidney, Andrew D. Cox, James C. Richards, E. Richard Moxon